Hemab Therapeutics Holdings, Inc. Common Stock (COAG) Expected Move

Expected move estimates the probable price range for a given period based on at-the-money options pricing. It reflects the market consensus for volatility over the selected timeframe.

Hemab Therapeutics Holdings, Inc. Common Stock (COAG) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $57.5M, listed on NASDAQ, employing roughly 59 people, carrying a beta of 0.00 to the broader market. Hemab Therapeutics Holdings, Inc. Led by Benny Sorensen, public since 2026-05-01.

Expected move analysis estimates the probable price range implied by options pricing. No recent options activity for COAG as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how expected move is reported and how to read the data →